Against the backdrop of the current health crisis, IRB Barcelona has been following the directives of the authorities to guarantee the health of its employees, to contribute to preventive measures to stop the spread of COVID-19, and to minimize the impact of these measures on the lines of research undertaken at the Institute. The aim is to guarantee minimum services and the maintenance of the Institute's research facilities and tools.
The work done by our computational scientists and many of the lab and administration tasks will continue to be undertaken. However, some projects have inevitably been suspended until things get back to normal and we can return to work. IRB Barcelona...
On 8 March, International Women´s Day, IRB Barcelona joined the international campaign Each for Equal. The institute is committed to promoting a working environment that values and fosters diversity equality and inclusion. Along the same lines, we participate in awareness campaigns such as that carried out for the International Day of Women and Girls in Science.
IRB Barcelona has an Equality and Diversity Committee, which is charged with developing and...
Headed by Eduard Batlle, the project will allow researchers to study the complexity and heterogeneity of cancer using culturable mini-cancers, also known as organoids, derived from patients.
The international ACCELERATOR call funds projects that allow research results to reach cancer patients faster.
On 26 March, the exhibition of IRB Barcelona´s first Artist in Residence will be launched at the Sant Pau Art Nouveau Site.
Rierola recreates Bosch´s work of the same name with images provided by researcher
This second art and science exhibition at this venue has been organised jointly by IRB Barcelona, the Quo Artis Foundation and the Sant Pau Art Nouveau Site.
Cancer is a worldwide health problem. Last year Spain registered 277,234 cancer diagnoses and this figure is growing. In Catalonia alone, 37,200 new cases were diagnosed last year and this figure is expected to reach 39,000 cases in 2025. This is why, today, on the occasion of World Cancer Day, we are joining the campaign “I am and I will” to showcase our commitment to the fight against this disease.
The Institute for Research in Biomedicine (IRB Barcelona) was founded 15 years ago with the mission to further research into cancer. Today its 450-strong community share a common goal: to contribute to the advance of biomedical sciences and improve quality of life by ensuring...
Each year the Fundación de Investigación del Cáncer de la Universidad de la Salamanca (FICUS) - Centro de Investigación del Cáncer (CIC) presents the 'Doctores Diz Pintado' Prize with the aim to promote and acknowledge the contribution of young Spanish researchers to Cancer Research.
Nostrum Biodiscovery, a spin-off from IRB Barcelona and the BSC-CNS, focuses on computational simulation to design new drugs and biotech molecules for the market.
The Senén Vilaró Prize is given each year by the “Consejo Social” of the UB and the Bosch i Gimpera Foundation to the best innovative company.
When you hear the word ‘immunotherapy’, the first thing that comes to mind is that it is a highly effective treatment for cancer. But could it also be the solution or hope for other conditions?
This was precisely the subject addressed at the Barcelona Biomed Conference “Immunotherapy beyond cancer. A cure for age-related diseases”, an event organised by the Institute for Research in Biomedicine (IRB Barcelona) from 18 to 20 November that brought together more than 100 scientists.
Over 3 days, researchers from all over the world have emphasized the potential of this new therapy for other applications. In this regard, Manuel Serrano...
Organised by PhD students and postdocs, ENABLE is aimed at the community of young researchers working in biomedicine.
The 3rd ENABLE symposium was held in Nijmegen (the Netherlands) from 13 to 15 November.
The symposium was cofunded by the European Commission and is managed and organised by four research institutes (IRB Barcelona, RIMLS, NNF CPR, and SEMM) and a science communication agency (Scienseed).
The jury unanimously decided to award Salvador Aznar Benitah in acknowledgement of his work on adult stem cells and the relation of these with circadian rhythms and metastasis, and also in recognition of his recent entrepreneurial activity.
The award is given in recognition of biochemistry and molecular biology research of excellence performed mainly in Spain.